About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

2016-9 Reports of Cases before the Court of Justice and the Court of First Instance 1 (2016)

handle is hein.intyb/rcbjcofi0384 and id is 1 raw text is: 





ZCVRLA


Reports   of  Cases


                       Case  C-412/15

  TMD  Gesellschaft fir transfusionsmedizinische Dienste mbH
                              V
              Finanzamt  Kassel 1I - Hofgeismar,


(Request for a preliminary ruling from the Hessisches Finanzgericht)


   (Reference for a preliminary ruling - Taxation - Value added tax - Directive 2006/112/EC -
   Exemptions for certain activities in the public interest - Article 132(1)(d) - Supplies of human
       organs, blood and milk - Scope - Plasma of human blood transformed and used for
                                     industrial purposes)


              Summary  -  Judgment of the Court (Third Chamber), 5 October 2016

Harmonisation  of fiscal legislation - Common  system of value added  tax -  Exemptions  -
Exemptions for certain activities in the public interest - Supplies of human organs, blood and milk -
Concept of human blood -  Plasma of human blood transformed and used for industrial purposes -
Not included

(Council Directive 2006/112, Art. 132(1)(d))


Article 132(1)(d) of Directive 2006/112 on the common system of value added tax must be interpreted
to the effect that supplies of human blood which Member States are required to exempt by virtue of
that provision do not include supplies of plasma obtained from human blood where that plasma is
intended to be used, not for direct therapeutic purposes, but exclusively for the manufacture of
medicinal products.

Article 132(1)(d) of Directive 2006/112 concerns only transactions directly linked to healthcare or
which have a therapeutic purpose. Therefore, so-called 'industrial' plasma, that is to say, plasma the
supply of which does not contribute directly to activities in the public interest, since it is intended to
be incorporated into an industrial production, in particular with a view to manufacturing medicinal
products, cannot come under  the exemption referred to in in that provision. Consequently, only
plasma  actually intended for direct therapeutic use comes under the exemption laid down in
Article 132(1)(d) of Directive 2006/112.

                                                        (see paras 31, 35, 36, 40, operative part)


ECLJ:EU:C:2016:7381


1

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most